ÀÖÌìÌÃappÏÂÔØ

Defeasance Provisions definition

Defeasance Provisions.ÌýAs set forth in the Indenture.
Defeasance Provisions.ÌýAs described in the Prospectus Supplement dated March 26, 2002.
Defeasance Provisions.ÌýDefeasance provisions set forth in Article IX of the Indenture shall apply to the Designated Securities. Closing Date, Time and Location: March 8, 2012, at 9:00 a.m., New York City time, at the offices of Xxxxxxx Xxxxxxx & Xxxxxxxx LLP, 000 Xxxxxxxxx Xxxxxx, Xxx Xxxx, Xxx Xxxx 00000. Names and Addresses of Representatives: As to the 2022 Notes and the 2042 Notes (and designated to act on behalf of the other Underwriters or other Representatives): Xxxxxxx Lynch, Pierce, Xxxxxx & Xxxxx Incorporated 00 Xxxxxxxxxxx Xxxxx XX0-000-00-0 Xxx Xxxx, Xxx Xxxx 00000 Attn: High Grade Legal/Transaction Management Barclays Capital Inc. 000 Xxxxxxx Xxxxxx Xxx Xxxx, Xxx Xxxx 00000 Citigroup Global Markets Inc. 000 Xxxxxxxxx Xxxxxx Xxx Xxxx, Xxx Xxxx 00000 Credit Suisse Securities (USA) LLC Xxx Xxxxxxx Xxxxxx Xxx Xxxx, Xxx Xxxx 00000 Attn: Prospectus Department â€� Final term sheet, dated March 5, 2012, relating to the 2022 Notes and the 2042 Notes, as filed pursuant to Rule 433 under the Securities Act. Issuer: UnitedHealth Group Incorporated Ratings*: [Intentionally omitted] Note Type: SEC Registered (No. 333-172235) Trade Date: Xxxxx 0, 0000 Xxxxxxxxxx Date (T+ 3): March 8, 2012 Title of Securities: 2.875% Notes Due March 15, 2022 (â€�2022 Notesâ€�) 4.375% Notes Due March 15, 2042 (â€�2042 Notesâ€�) Maturity Date: March 15, 2022 (2022 Notes) March 15, 2042 (2042 Notes) Principal Amount Offered: $600,000,000 (2022 Notes) $400,000,000 (2042 Notes) Price to Public (Issue Price): 99.310% (2022 Notes) 99.833% (2042 Notes) Interest Rate: 2.875% (2022 Notes) 4.375% (2042 Notes) Interest Payment Dates: March 15 and September 15, commencing September 15, 0000 Xxxxxxxxx: 2.000% due 02/15/2022 (2022 Notes) 3.125% due 11/15/2041 (2042 Notes) Benchmark Yield: 2.005% (2022 Notes) 3.135% (2042 Notes) Spread to Benchmark: 95 basis points (2022 Notes) 125 basis points (2042 Notes) Re-offer Yield: 2.955% (2022 Notes) 4.385% (2042 Notes) Optional Redemption Provisions: Prior to December 15, 2021, make-whole call at any time at a discount rate of U.S. Treasury plus 15 basis points; par call on and after December 15, 2021. (2022 Notes) Prior to September 15, 2041, make-whole call at any time at a discount rate of U.S. Treasury plus 20 basis points; par call on and after September 15, 2041. (2042 Notes)

Examples of Defeasance Provisions in a sentence

  • Sinking Fund Provisions: No sinking fund provisions Defeasance Provisions: Legal defeasance and covenant defeasance permitted upon compliance with conditions set forth in the Indenture Additional Terms: Except as otherwise provided in this Schedule II, such other terms are specified in the Pricing Prospectus.

  • Sinking Fund Provisions: No sinking fund provisions Defeasance Provisions: Legal defeasance and covenant defeasance permitted upon compliance with conditions set forth in the Indenture Additional Terms: Except as otherwise provided in this Schedule II-1, such other terms are specified in the Pricing Prospectus.

  • Sinking Fund Provisions: No sinking fund provisions Defeasance Provisions: Legal defeasance and covenant defeasance permitted upon compliance with conditions set forth in the Indenture Additional Terms: Except as otherwise provided in this Schedule II-2, such other terms are specified in the Pricing Prospectus.

  • Defeasance Provisions: As described in the Basic Prospectus dated February 26, 2018.

  • On-Sale Clauses; Assumption Agreements; Defeasance Provisions SECTION 3.10.


More Definitions of Defeasance Provisions

Defeasance Provisions.ÌýDefeasance provisions set forth in Article IX of the Indenture shall apply to the Designated Securities. July 23, 2015, at 9:00 a.m. (New York City time) at the offices of Xxxxxxx Xxxxxxx & Xxxxxxxx LLP, 000 Xxxxxxxxx Xxxxxx, Xxx Xxxx, Xxx Xxxx 00000. As to the Floating Rate Notes, 2017 Notes, the 2018 Notes, the 2020 Notes, the 2022 Notes, the 2025 Notes, the 2035 Notes and the 2045 Notes (and designated to act on behalf of the other Underwriters or other Representatives): X.X. Xxxxxx Securities LLC 000 Xxxxxxx Xxxxxx Xxx Xxxx, Xxx Xxxx 00000 Attention: Investment Grade Syndicate Desk â€� 3rd floor Barclays Capital Inc. 000 Xxxxxxx Xxxxxx Xxx Xxxx, Xxx Xxxx 00000 Attention: Syndicate Registration Citigroup Global Markets Inc. 000 Xxxxxxxxx Xxxxxx Xxx Xxxx, Xxx Xxxx 00000 Attention: General Counsel Facsimile: (000) 000-0000 Xxxxxxx Lynch, Pierce, Xxxxxx & Xxxxx Incorporated 00 Xxxxxxxxxxx Xxxxx XX0-000-00-00 Xxx Xxxx, Xxx Xxxx 00000 Attention: High Grade Transaction Management/Legal Facsimile: (000) 000-0000 Xxxxxx Xxxxxxx & Co. LLC 0000 Xxxxxxxx Xxx Xxxx, Xxx Xxxx 00000 Attention: Investment Banking Division UBS Securities LLC 0000 Xxxxxx xx xxx Xxxxxxxx Xxx Xxxx, Xxx Xxxx 00000 Attention: Fixed Income Syndicate â€� Final term sheet, dated July 20, 2015, relating to the Floating Rate Notes, the 2017 Notes, the 2018 Notes, the 2020 Notes, the 2022 Notes, the 2025 Notes, the 2035 Notes and the 2045 Notes, as filed pursuant to Rule 433 under the Securities Act. Issuer: UnitedHealth Group Incorporated Ratings (Xxxxx’x / S&P / Fitch)*: [Intentionally Omitted] Note Type: SEC Registered (No. 333-193958) Trade Date: July 20, 2015 Settlement Date (T+3): July 23, 2015 Maturity Date: January 17, 2017 Principal Amount Offered: $750,000,000 Price to Public (Issue Price): 100.000% Base Rate Spread: LIBOR +45 basis points Interest Payment Dates and Interest Reset Dates: January 17, April 17, July 17 and October 17, commencing October 17, 2015 (short first coupon) Optional Redemption Provisions: None.
Defeasance Provisions.ÌýSubject to the defeasance and covenant defeasance provisions of Article 15 of the Indenture, dated as of June 1, 1986, between the Company and The Chase Manhattan Bank (formerly Chemical Bank, successor by merger to Manufacturers Hanover Trust Company), as Trustee.
Defeasance Provisions.ÌýDefeasance provisions set forth in Article IX of the Indenture shall apply to the Designated Securities. March 13, 2017, at 9:00 a.m. (New York City time) at the offices of Xxxxxxx Xxxxxxx & Xxxxxxxx LLP, 000 Xxxxxxxxx Xxxxxx, Xxx Xxxx, Xxx Xxxx 00000.
Defeasance Provisions.ÌýAs set forth in the Indenture. GUARANTORS: Brandywine Realty Trust and the Subsidiary Guarantors named in the Prospectus Supplement dated the date hereof relating to the Designated Securities.
Defeasance Provisions.ÌýAs described in the Prospectus Supplement dated June 6, 2002.